Justin Pham was 30 years old when he was told his kidney function had declined to the point that the organs could no longer function on their own. This diagnosis came as a huge shock to Pham, from Los ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Nate Robinson, the 11-year NBA veteran who won the league's Slam Dunk Contest three times, revealed on Instagram that he had ...

A groundbreaking study has identified how previously mysterious mutations in non-coding DNA contribute to kidney disease, ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Former NBA guard Nate Robinson has been dealing with renal failure for the past seven years, but relief is on the way.

Kidney disease affects millions of Americans, with Black communities facing disproportionately higher risks due to genetic factors, socioeconomic challenges, ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...